Surgical Science Sweden AB (publ) (STO: SUS)

Market Cap	8.93B
Revenue (ttm)	859.83M
Net Income (ttm)	193.34M
Shares Out	51.03M
EPS (ttm)	3.79
PE Ratio	46.20
Forward PE	39.03
Dividend	n/a
Ex-Dividend Date	n/a

Volume	33,753
Average Volume	125,218
Open	176.80
Previous Close	176.40
Day's Range	174.00 - 177.70
52-Week Range	111.80 - 186.40
Beta	0.93
RSI	67.90
Earnings Date	Feb 19, 2025

About STO: SUS

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy tra...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1997
• Employees: 260
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SUS

Financial Performance

In 2023, SUS's revenue was 882.85 million, an increase of 10.01% compared to the previous year's 802.54 million. Earnings were 233.97 million, an increase of 24.47%.